Pfizer To Merge Off-Patent Business With Mylan

Pfizer
Pfizer Has Announced Plans To Merge Its Off-Patent Unit With Mylan • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business